Icyiciro cya farumasi Icyiciro 1009119-65-6 Daclatasvir yo kuvura Hepatite C Igishusho cyihariye

Icyiciro cya farumasi 1009119-65-6 Daclatasvir yo kuvura Hepatite C.

Ibisobanuro bigufi:

Isuku:9. 99.0%

Ibipimo ngenderwaho:Nkuko bisabwa

Icyemezo:COA, MOA, MSDS, nibindi

Ubushobozi:50Kgs ku kwezi

Ubuzima bwa Shelf:Imyaka ibiri

Gusaba:inhibitor ya proteine 5A itubatswe kandi ikoreshwa mukuvura hepatite C.

Ibyiza by'itsinda:Inararibonye yo kugurisha ibicuruzwa hanze hamwe namahugurwa yumwuga muruganda

Ohereza imeri kuri twe Kuramo nka PDF

Ibicuruzwa birambuye

Ibibazo

Ibicuruzwa

Ibicuruzwaizina	Daclatasvir2HCl
Synonyme	N, N '- [[1,1'-Biphenyl] -4,4′-diylbis -methylethyl) -2-oxo-2,1-ethanediyl]]] aside biscarbamic dimethyl ester hydrochloride;BMS 790052
URUBANZA No.	1009119-65-6
Kugaragara	Ifu yera yijimye
Inzira ya molekulari	C₄₀H₅₀N₈O₆.2 (HCl)
Uburemere bwa molekile	811.81
Ikoreshwa	Icyiciro cya farumasi kubushakashatsi bugamije
Gupakira	Nkurikije icyifuzo cyawe
Ububiko	Bika mubintu byoroshye, birinda urumuri ahantu hakonje

Daclatasvir2HCl Cas:1009119-65-6
Ibintu	Bisanzwe	Ibisubizo
Ibiranga	Ifu yera yijimye	Ifu yumuhondo
Ibirimo amazi	≦ 1.0%	0,25%
Isuku	≧ 99%	99.7%
Umwanda umwe	≦ 0.1%	0.06%
Ibisigisigi byo gutwikwa	≦ 0.1%	Bikubiyemo
Umwanzuro	Yubahiriza hamwe murugo.

Amakuru yisosiyete

Experience Inzego zubuyobozi zifite uburambe mu ruganda hamwe nabatekinisiye babishoboye;
Uality Ubwiza burigihe twibanze hejuru, Sisitemu ya QC;
Years Imyaka 11 ifite uburambe bwo kohereza ibicuruzwa hanze;
Lab Laboratwari yigenga ya R&D;
√ Amahugurwa abiri yashyizweho umukono igihe kirekire GMP;
Resources Ibikoresho byinshi byinganda zidafite akamaro kumushinga wabigenewe;
Team Itsinda rikora neza rifite inzira ihamye.
imgsaf